X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8853) 8853
Newsletter (2742) 2742
Publication (694) 694
Newspaper Article (62) 62
Book Review (24) 24
Book Chapter (19) 19
Dissertation (8) 8
Magazine Article (8) 8
Conference Proceeding (6) 6
Reference (4) 4
Transcript (4) 4
Trade Publication Article (2) 2
Book / eBook (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
deoxycholic acid (7560) 7560
animals (3411) 3411
humans (3133) 3133
index medicus (2432) 2432
male (2252) 2252
research (1893) 1893
deoxycholic acid - pharmacology (1818) 1818
female (1490) 1490
rats (1446) 1446
analysis (1289) 1289
physiological aspects (1125) 1125
reports (1078) 1078
biochemistry & molecular biology (981) 981
liver (956) 956
bile acids and salts - metabolism (944) 944
mice (909) 909
bile acids (889) 889
adult (768) 768
middle aged (747) 747
pharmacology & pharmacy (746) 746
cholesterol (702) 702
kinetics (664) 664
bile (661) 661
deoxycholic acid - analogs & derivatives (628) 628
gastroenterology & hepatology (608) 608
deoxycholic acid - metabolism (525) 525
universities and colleges (497) 497
liver - metabolism (481) 481
deoxycholic-acid (459) 459
cancer (456) 456
deoxycholic acid - chemistry (456) 456
medical research (449) 449
aged (442) 442
acids (436) 436
solubility (430) 430
medicine, experimental (428) 428
hydrogen-ion concentration (423) 423
metabolism (421) 421
liver diseases (419) 419
time factors (402) 402
bile-acids (388) 388
ursodeoxycholic acid (383) 383
bile acid (376) 376
proteins (373) 373
microbiology (368) 368
expression (367) 367
protein binding (364) 364
enzymes (360) 360
apoptosis (348) 348
health aspects (348) 348
bile acids and salts - pharmacology (338) 338
care and treatment (337) 337
cholestasis (330) 330
cholesterol - metabolism (330) 330
deoxycholic acid - administration & dosage (330) 330
mass spectrometry (325) 325
gene expression (316) 316
cytochrome p-450 (313) 313
lipids (309) 309
research article (307) 307
cell biology (301) 301
drugs (301) 301
drug combinations (298) 298
surgery (297) 297
cholic acid (295) 295
rabbits (292) 292
in vitro techniques (288) 288
ursodeoxycholic acid - therapeutic use (288) 288
article (286) 286
obesity (285) 285
bile acids and salts - analysis (282) 282
glucose (282) 282
microbiota (282) 282
micelles (281) 281
dose-response relationship, drug (277) 277
chenodeoxycholic acid (273) 273
rats, sprague-dawley (269) 269
diet (267) 267
biophysics (264) 264
liver - drug effects (263) 263
metabolites (258) 258
molecular weight (258) 258
methods (257) 257
oncology (257) 257
physical fitness (257) 257
deoxycholic acid - therapeutic use (255) 255
bile acids and salts - blood (250) 250
bile acids and salts - chemistry (250) 250
cattle (250) 250
gastroenterology and hepatology (245) 245
endocrinology & metabolism (243) 243
biochemistry (241) 241
chemistry (238) 238
in-vitro (237) 237
cells, cultured (235) 235
rodents (235) 235
fatty acids (233) 233
rats, inbred strains (229) 229
cells (227) 227
amphotericin b (226) 226
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11250) 11250
German (83) 83
Japanese (77) 77
Russian (69) 69
French (58) 58
Chinese (57) 57
Spanish (31) 31
Italian (28) 28
Korean (14) 14
Polish (7) 7
Ukrainian (6) 6
Czech (3) 3
Portuguese (3) 3
Dutch (2) 2
Bulgarian (1) 1
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 11/2018, Volume 48, Issue 9, pp. 1034 - 1035
Linked Content This article is linked to Damsgaard et al and Walters papers. To view these articles visit https://doi.org/10.1111/apt.14533 and... 
GASTROENTEROLOGY & HEPATOLOGY | PHARMACOLOGY & PHARMACY | MALABSORPTION | Diarrhea | Retrospective Studies | Bile Acids and Salts | Taurocholic Acid - analogs & derivatives | Humans | Chenodeoxycholic Acid - analogs & derivatives | Deoxycholic acid | Acids | Bile
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2015, Volume 62, Issue 6, pp. 1398 - 1404
Graphical abstract 
Gastroenterology and Hepatology | 3-hydroxy-3-methylglutaryl-CoA reductase | Stearoyl-CoA desaturase | Non-alcoholic fatty liver disease | Lipogenesis | FGF19 | 3-hydroxy-3-methylglutaryl- CoA reductase | FXR | NONALCOHOLIC STEATOHEPATITIS | AGONISTS | NUCLEAR RECEPTOR | CHOLESTEROL-METABOLISM | TRANSPORT | FEEDBACK-REGULATION | LIVER | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | ADIPOSE-TISSUE | Ursodeoxycholic Acid - administration & dosage | Oleic Acid - metabolism | Bile Acids and Salts - biosynthesis | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Intra-Abdominal Fat - metabolism | Obesity, Morbid - drug therapy | Non-alcoholic Fatty Liver Disease - drug therapy | Ursodeoxycholic Acid - pharmacology | Stearoyl-CoA Desaturase - biosynthesis | Liver - drug effects | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Lipid Metabolism - drug effects | Intra-Abdominal Fat - drug effects | Obesity, Morbid - metabolism | Physiological aspects | Obesity | Ursodiol | Deoxycholic acid | Index Medicus | BAs, bile acids | nCEH, neutral cholesterol ester hydrolase | ApoB, apolipoprotein B | LDLR, low density lipoprotein receptor | FGF19, fibroblast growth factor 19 | VLDL, very low density lipoproteins | ABC, ATP-binding cassette | TGs, triglycerides | NAFLD, non-alcoholic fatty liver disease | OA, oleic acid | C4, 7α-hydroxy-4-cholesten-3-one | SHP, small heterodimer partner | SREBP1c, sterol regulatory element-binding protein-1c | CA, cholic acid | PA, palmitic acid | FATP1, fatty acid transport protein 1 | UDCA, ursodeoxycholic acid | FAs, fatty acides | HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase | vWAT, visceral white adipose tissue | SCD, stearoyl-Coa desaturase | CYP7A1, cholesterol 7α-hydroxylase | NASH, non-alcoholic steatohepatitis | FXR, farnesoid X receptor | CDCA, chenodeoxycholic acid | MA, myristic acid | FASN, fatty acid synthase | MTTP, microsomal triglyceride transfer protein | SA, stearic acid | NONALCOHOLIC | FATTY LIVER-DISEASE | Gastroenterology & Hepatology | Endokrinologi och diabetes | STEATOHEPATITIS | PLACEBO-CONTROLLED TRIAL | COA DESATURASE | Endocrinology and Diabetes
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 1, pp. 155 - 168
Summary Bile acid (BA) transporters are critical for maintenance of the enterohepatic BA circulation where BAs exert their multiple physiological functions... 
Gastroenterology and Hepatology | Gallstones | Liver cancer | Bile acids | Fatty liver disease | Cholestasis | Liver regeneration | RAT-LIVER | SALT EXPORT PUMP | GROWTH-FACTOR 19 | ORGANIC ANION TRANSPORTERS | 90-PERCENT PARTIAL-HEPATECTOMY | URSODEOXYCHOLIC ACID | PRIMARY BILIARY-CIRRHOSIS | FARNESOID-X-RECEPTOR | GASTROENTEROLOGY & HEPATOLOGY | PHOSPHOLIPID-ASSOCIATED CHOLELITHIASIS | FAMILIAL INTRAHEPATIC CHOLESTASIS | Animals | Carrier Proteins - metabolism | Cholestasis - metabolism | Membrane Glycoproteins - metabolism | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Liver Diseases - metabolism | Liver Regeneration - physiology | Receptors, Cytoplasmic and Nuclear - metabolism | Drug resistance in microorganisms | Corticosteroids | Glucagon | Calcifediol | Ursodiol | Deoxycholic acid | Epidermal growth factor | Vitamin D | Physiological aspects | Fibroblast growth factors | Alfacalcidol | IBABP (FABP6, ILBP), intestinal bile acid-binding protein, fatty acid-binding protein 6 | PFIC, progressive familial intrahepatic cholestasis | TNFα, tumor necrosis factor α | 3 (human) | SRC2, p160 steroid receptor coactivator | NAFLD, non-alcoholic fatty liver disease | BA, bile acid | bile acid receptor | 8, cholesterol efflux pump, ATP-binding cassette, subfamily G, member 5 | UDCA, ursodeoxycholic acid | LRH-1 (NR5A2), liver receptor homolog-1 | LCA, lithocholic acid | LXRα (NR1H3), liver X receptor alpha | PPARγ (NR1C3), peroxisome proliferator-activated receptor gamma | OSTαβ, organic solute transporter alpha | ABCG5 | AMPK, AMP activated protein kinase | NASH, non-alcoholic steatohepatitis | SHP (NR0B2), short heterodimer partner | OATP1A2 (SLCO1A2, OATP1, OATP-A, SLC21A3), solute carrier organic anion transporter family, member 1A2 | EGFR, epidermal growth factor receptor | IL6, interleukin 6 | TGR5, G protein-coupled bile acid receptor | PH, partial hepatectomy | AE2, anion exchanger 2 | PSC, primary sclerosing cholangitis | OATP1B1 (SLCO1B1, OATP2, OATP-C, SLC21A6), solute carrier organic anion transporter family, member 1B1 | RARα (NR1B1), retinoic acid receptor alpha | GLP-1, glucagon like peptide 1 | VDR (NR1I1), vitamin D receptor. Please note that for the convenience of better readability and clarity, abbreviations for transporters and nuclear receptors were capitalized throughout this article when symbols were identical for human and rodents | MRP2 (ABCC2), multidrug resistance-associated protein 2, ATP-binding cassette, subfamily C, member 2 | NTCP (SLC10A1), sodium | CAR (NR1I3), constitutive androstane receptor | taurocholate cotransporting polypeptide, solute carrier family 10, member 1 | PPARα (NR1C1), peroxisome proliferator-activated receptor alpha | Review | GR (NR3C1), glucocorticoid receptor | Bile acids, Cholestasis, Fatty liver disease, Gallstones, Liver regeneration, Liver cancer | 19, fibroblast growth factor 15 | Mdr2 | ICP, intrahepatic cholestasis of pregnancy | BRIC, benign recurrent intrahepatic cholestasis | OATP1B3 (SLCO1B3, OATP8, SLC21A8), solute carrier organic anion transporter family, member 1B3 | MRP3 (ABCC3), multidrug resistance-associated protein 3, ATP-binding cassette, subfamily C, member 3 | beta | MDR1 (ABCB1), p-glycoprotein, ATP-binding cassette, subfamily B, member 1 | norUDCA, norursodeoxycholic acid | 6-ECDCA, 6-ethylchenodeoxycholic acid | FXR (NR1H4), farnesoid X receptor | BCRP (ABCG2), breast cancer resistance protein, ATP-binding cassette, subfamily G, member 2 | HNF4α (NR2A1), hepatocyte nuclear factor 4 alpha | PBC, primary biliary cirrhosis | MDR3 (ABCB4), multidrug resistance protein 2 (rodents) | HNF1α, hepatocyte nuclear factor 1 alpha | NR, nuclear receptor | FGF15 | RXRα (NR2B1), retinoid X receptor alpha | PXR (NR1I2), pregnane X receptor | BSEP (ABCB11), bile salt export pump | HCC, hepatocellular carcinoma | MRP4 (ABCC4), multidrug resistance-associated protein 4, ATP-binding cassette, subfamily C, member 4 | TPN, total parenteral nutrition
Journal Article
FASEB Journal, ISSN 0892-6638, 09/2017, Volume 31, Issue 9, pp. 3848 - 3857
Journal Article
Molecular Metabolism, ISSN 2212-8778, 04/2019, Volume 22, pp. 96 - 109
The gut microbiota is an important influencing factor of metabolic health. Although dietary interventions with probiotics, prebiotics, and synbiotics can be... 
Gut microbiota | Obesity | Dietary intervention | High-fat diet | Synbiotics | PHYSIOLOGY | HIGH-FAT-DIET | PROBIOTICS | OLIGOFRUCTOSE | GENOME SEQUENCE | OVERWEIGHT | PREBIOTICS | ENDOCRINOLOGY & METABOLISM | SP-NOV | INTERVENTION | BILE-ACIDS | Index Medicus
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 11/2018, Volume 48, Issue 9, pp. 1032 - 1034
Linked Content This article is linked to Damsgaard et al papers. To view these articles visit https://doi.org/10.1111/apt.14533 and... 
GASTROENTEROLOGY & HEPATOLOGY | PHARMACOLOGY & PHARMACY | Diarrhea | Retrospective Studies | Bile Acids and Salts | Taurocholic Acid - analogs & derivatives | Humans | Chenodeoxycholic Acid - analogs & derivatives | Deoxycholic acid | Acids | Bile
Journal Article
Dermatologic Surgery, ISSN 1076-0512, 04/2017, Volume 43, Issue 4, pp. 609 - 610
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 06/2013, Volume 169, Issue 3, pp. 671 - 684
Background and Purpose Nutrient sensing in the gut is believed to be accomplished through activation of GPCRs expressed on enteroendocrine cells. In... 
glucagon‐like peptide 1 | cyclic adenosine monophosphate | glucose tolerance | bile acid | incretin | GLP‐1 secretion | glucagon-like peptide 1 | GLP-1 secretion | CELLS | PEPTIDE-YY | ACTIVATION | FOOD-INTAKE | TGR5 | INHIBITION | COLESEVELAM | GLUCOSE | PHARMACOLOGY & PHARMACY | EXPRESSION | INCRETIN SECRETION | Cricetulus | Isonipecotic Acids - pharmacology | Oximes - pharmacokinetics | Receptors, G-Protein-Coupled - metabolism | Hypoglycemic Agents - metabolism | Humans | Macaca fascicularis | Oximes - therapeutic use | Male | Diabetes Mellitus, Type 2 - metabolism | Receptors, G-Protein-Coupled - agonists | Peptide YY - secretion | Enteroendocrine Cells - secretion | Glucagon-Like Peptide 1 - secretion | Piperidines - pharmacology | Mice, Mutant Strains | Oximes - metabolism | Piperidines - pharmacokinetics | Enteroendocrine Cells - metabolism | Gastrointestinal Agents - pharmacokinetics | CHO Cells | Hypoglycemic Agents - therapeutic use | Recombinant Proteins - metabolism | Cell Line | Hypoglycemic Agents - pharmacokinetics | Isonipecotic Acids - pharmacokinetics | Metabolic Detoxication, Phase II | Piperidines - metabolism | Recombinant Proteins - chemistry | Mice, Transgenic | Isonipecotic Acids - therapeutic use | Hypoglycemic Agents - pharmacology | Isonipecotic Acids - metabolism | Gastrointestinal Agents - pharmacology | Animals | Piperidines - therapeutic use | Gastrointestinal Agents - therapeutic use | Oximes - pharmacology | Mice | Receptors, G-Protein-Coupled - genetics | Diabetes Mellitus, Type 2 - drug therapy | Enteroendocrine Cells - drug effects | Taurine - metabolism | Gastrointestinal Agents - metabolism | Glucose metabolism | Taurine | Glucagon | Monkeys | Glucose | G proteins | Dextrose | Deoxycholic acid | Rodents | Bioavailability | Bile | Research Papers
Journal Article